Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

PubMed Links for Books (Select 2824826)

1.

Suicide and suicide attempt after a cancer diagnosis among young individuals.

Lu D, Fall K, Sparén P, Ye W, Adami HO, Valdimarsdóttir U, Fang F.

Ann Oncol. 2013 Dec;24(12):3112-7. doi: 10.1093/annonc/mdt415. Epub 2013 Oct 29.

2.

Quality varies across clinical practice guidelines for mammography screening in women aged 40-49 years as assessed by AGREE and AMSTAR instruments.

Burda BU, Norris SL, Holmer HK, Ogden LA, Smith ME.

J Clin Epidemiol. 2011 Sep;64(9):968-76. doi: 10.1016/j.jclinepi.2010.12.005. Epub 2011 Mar 21. Review.

PMID:
21420280
3.

Cancer screening among patients with advanced cancer.

Sima CS, Panageas KS, Schrag D.

JAMA. 2010 Oct 13;304(14):1584-91. doi: 10.1001/jama.2010.1449.

4.

Cumulative incidence of false-positive results in repeated, multimodal cancer screening.

Croswell JM, Kramer BS, Kreimer AR, Prorok PC, Xu JL, Baker SG, Fagerstrom R, Riley TL, Clapp JD, Berg CD, Gohagan JK, Andriole GL, Chia D, Church TR, Crawford ED, Fouad MN, Gelmann EP, Lamerato L, Reding DJ, Schoen RE.

Ann Fam Med. 2009 May-Jun;7(3):212-22. doi: 10.1370/afm.942.

5.

Prospective evaluation of whole-body cancer screening with multiple modalities including [18F]fluorodeoxyglucose positron emission tomography in a healthy population: a preliminary report.

Nishizawa S, Kojima S, Teramukai S, Inubushi M, Kodama H, Maeda Y, Okada H, Zhou B, Nagai Y, Fukushima M.

J Clin Oncol. 2009 Apr 10;27(11):1767-73. doi: 10.1200/JCO.2008.18.2238. Epub 2009 Mar 2.

6.

Evaluating new screening tests for breast cancer.

Irwig L, Houssami N, Armstrong B, Glasziou P.

BMJ. 2006 Mar 25;332(7543):678-9. No abstract available.

7.

Non-cancer mortality among people diagnosed with cancer (Australia).

Baade PD, Fritschi L, Eakin EG.

Cancer Causes Control. 2006 Apr;17(3):287-97.

PMID:
16489536
8.

Health and economic benefits of well-designed evaluations: some lessons from evaluating neuroblastoma screening.

Soderstrom L, Woods WG, Bernstein M, Robison LL, Tuchman M, Lemieux B.

J Natl Cancer Inst. 2005 Aug 3;97(15):1118-24.

9.

Confounding by dietary factors in case-control studies on the efficacy of cancer screening in Japan.

Suzuki KJ, Nakaji S, Tokunaga S, Shimoyama T, Umeda T, Sugawara K.

Eur J Epidemiol. 2005;20(1):73-8.

PMID:
15756907
10.

The science of early detection.

Kramer BS.

Urol Oncol. 2004 Jul-Aug;22(4):344-7. Review.

PMID:
15283894
11.

All-cause mortality in randomized trials of cancer screening.

Black WC, Haggstrom DA, Welch HG.

J Natl Cancer Inst. 2002 Feb 6;94(3):167-73.

12.

Screening for breast cancer with mammography.

Olsen O, Gøtzsche PC.

Cochrane Database Syst Rev. 2001;(4):CD001877. Review. Update in: Cochrane Database Syst Rev. 2006;(4):CD001877.

PMID:
11687128
13.

Overdiagnosis: An underrecognized cause of confusion and harm in cancer screening.

Black WC.

J Natl Cancer Inst. 2000 Aug 16;92(16):1280-2. No abstract available.

14.

Are increasing 5-year survival rates evidence of success against cancer?

Welch HG, Schwartz LM, Woloshin S.

JAMA. 2000 Jun 14;283(22):2975-8.

PMID:
10865276
15.

A population-based study of the usefulness of screening for neuroblastoma.

Woods WG, Tuchman M, Robison LL, Bernstein M, Leclerc JM, Brisson LC, Brossard J, Hill G, Shuster J, Luepker R, Byrne T, Weitzman S, Bunin G, Lemieux B.

Lancet. 1996 Dec 21-28;348(9043):1682-7.

PMID:
8973429
16.

Effects of mass screening on age-specific incidence of neuroblastoma.

Bessho F.

Int J Cancer. 1996 Aug 7;67(4):520-2.

PMID:
8759611
17.

Case-control studies of screening efficacy: the use of persons newly diagnosed with cancer who later sustain an unfavorable outcome.

Weiss NS, Lazovich D.

Am J Epidemiol. 1996 Feb 15;143(4):319-22. Review. No abstract available.

18.

Mass screening and age-specific incidence of neuroblastoma in Saitama Prefecture, Japan.

Yamamoto K, Hayashi Y, Hanada R, Kikuchi A, Ichikawa M, Tanimura M, Yoshioka S.

J Clin Oncol. 1995 Aug;13(8):2033-8.

PMID:
7636545
19.

Screening for prostate cancer with prostate-specific antigen. An examination of the evidence.

Woolf SH.

N Engl J Med. 1995 Nov 23;333(21):1401-5. Review. No abstract available.

PMID:
7477122
20.

Case-control studies of screening.

Moss SM.

Int J Epidemiol. 1991 Mar;20(1):1-6. Review.

PMID:
2066205
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk